Evidence map›Paper›PMID 33044703›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2020

Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.

Anne M Evans, Claire O'Donovan, Mary Playdon, Chris Beecher, Richard D Beger, John A Bowden, David Broadhurst, Clary B Clish, Surendra Dasari, Warwick B Dunn and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 8 countries.

Anne M EvansMetabolon, Morrisville, NC, USA. aevans@metabolon.com.ORCID 0000-0002-0827-276X
Claire O'DonovanEuropean Molecular Biology Laboratory (EMBL), The European Bioinformatics Institute, Cambridgeshire, UK.ORCID 0000-0001-8051-7429
Mary PlaydonUniversity of Utah, Salt Lake City, Utah, USA.ORCID 0000-0001-6082-0447
Chris BeecherIROA Technologies, Chapel Hill, NC, USA.ORCID 0000-0003-4934-7278
Richard D BegerNational Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, USA.ORCID 0000-0003-4380-2356
John A BowdenCollege of Veterinary Medicine, University of Florida, Gainesville, FL, USA.ORCID 0000-0003-3135-4015
David BroadhurstCentre for Integrative Metabolomics & Computational Biology, School of Science, Edith Cowan University, Joondalup, WA, Australia.ORCID 0000-0003-0775-9581
Clary B ClishBroad Institute, Cambridge, MA, USA.ORCID 0000-0001-8259-9245
Surendra DasariDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7972-3556
Warwick B DunnSchool of Biosciences, Phenome Centre Birmingham and Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.ORCID 0000-0001-6924-0027
Julian L GriffinDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1336-7744
Thomas HartungCenter for Alternatives To Animal Testing (CAAT), Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0003-1359-7689
Ping- Ching HsuUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Tao HuanDepartment of Chemistry, University of British Columbia, Vancouver, Canada.ORCID 0000-0001-6295-2435
Judith JansUniversity Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0003-0960-6263
Christina M JonesMaterial Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA.ORCID 0000-0001-7571-3062
Maureen KachmanUniversity of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-9996-8446
Andre KleensangCenter for Alternatives To Animal Testing (CAAT), Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-4564-7399
Matthew R LewisNational Phenome Centre, Imperial College London, London, UK.ORCID 0000-0001-5760-5359
María Eugenia MongeCentro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET), C1425FQD, Ciudad de Buenos Aires, Argentina.ORCID 0000-0001-6517-5301
Jonathan D MosleyCenter for Environmental Measurement and Modeling, Environmental Protection Agency, Washington, DC, USA.ORCID 0000-0002-9300-6924
Eric TaylorUniversity of Iowa, Iowa City, Iowa, USA.ORCID 0000-0003-4549-6567
Fariba TayyariDepartment of Internal Medicine, Metabolomics Core, The University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0002-5837-9231
Georgios TheodoridisAristotle University, Thessaloniki, Greece.ORCID 0000-0002-2015-108X
Federico TortaSingapore Lipidomics Incubator, Department of Biochemistry, Life Sciences Institute and Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore.ORCID 0000-0001-7545-7484
Baljit K UbhiSciex, Redwood, USA.
Dajana VuckovicConcordia University, Montreal, QC, Canada.ORCID 0000-0002-7764-8492
Metabolomics Quality Assurance, Quality Control Consortium (mQACC)
Johns Hopkins University · USUniversity of Iowa · USAristotle University of Thessaloniki · GRBroad Institute · USConcordia University · CAConsejo Nacional de Investigaciones Científicas y Técnicas · AREdith Cowan University · AUEnvironmental Protection Agency · USEuropean Bioinformatics Institute · GBImperial College London · GBMayo Clinic in Florida · USMetabolon (United States) · USNational Center for Toxicological Research · USNational Institute of Standards and Technology · USNational University of Singapore · SGUniversity Medical Center Utrecht · NLUniversity of Arkansas for Medical Sciences · USUniversity of Birmingham · GBUniversity of British Columbia · CAUniversity of Cambridge · GB

Funding

Regulation of Hepatic Macronutrient Metabolism by Mitochondrial Citrate TransportR01DK104998 · NIDDK · UNIVERSITY OF IOWA · PI TAYLOR, ERIC B · 2015 to 2022
$3.2M
Blood metabolite profiles and risk of developing endometrial cancerR00CA218694 · NCI · UNIVERSITY OF UTAH · PI PLAYDON, MARY CHRISTINE · 2018 to 2020
$747k
Intramural EPA EPA999999Medical Research Council MC_PC_13030Medical Research Council MC_UP_A090_1006Medical Research Council MR/M009157/1Medical Research Council MR/P011705/1Medical Research Council MR/P01836X/1Medical Research Council MR/S019669/1NCI NIH HHS R00 CA218694NIDDK NIH HHS R01 DK104998
6 · The paper itself

Abstract

introductionThe metabolomics quality assurance and quality control consortium (mQACC) evolved from the recognized need for a community-wide consensus on improving and systematizing quality assurance (QA) and quality control (QC) practices for untargeted metabolomics.

objectivesIn this work, we sought to identify and share the common and divergent QA and QC practices amongst mQACC members and collaborators who use liquid chromatography-mass spectrometry (LC-MS) in untargeted metabolomics.

methodsAll authors voluntarily participated in this collaborative research project by providing the details of and insights into the QA and QC practices used in their laboratories. This sharing was enabled via a six-page questionnaire composed of over 120 questions and comment fields which was developed as part of this work and has proved the basis for ongoing mQACC outreach.

resultsFor QA, many laboratories reported documenting maintenance, calibration and tuning (82%); having established data storage and archival processes (71%); depositing data in public repositories (55%); having standard operating procedures (SOPs) in place for all laboratory processes (68%) and training staff on laboratory processes (55%). For QC, universal practices included using system suitability procedures (100%) and using a robust system of identification (Metabolomics Standards Initiative level 1 identification standards) for at least some of the detected compounds. Most laboratories used QC samples (>86%); used internal standards (91%); used a designated analytical acquisition template with randomized experimental samples (91%); and manually reviewed peak integration following data acquisition (86%). A minority of laboratories included technical replicates of experimental samples in their workflows (36%).

conclusionsAlthough the 23 contributors were researchers with diverse and international backgrounds from academia, industry and government, they are not necessarily representative of the worldwide pool of practitioners due to the recruitment method for participants and its voluntary nature. However, both questionnaire and the findings presented here have already informed and led other data gathering efforts by mQACC at conferences and other outreach activities and will continue to evolve in order to guide discussions for recommendations of best practices within the community and to establish internationally agreed upon reporting standards. We very much welcome further feedback from readers of this article.

Indexed as

Chromatography, LiquidHumansLaboratoriesMass SpectrometryMetabolomicsQuality ControlResearch DesignSurveys and QuestionnairesLC-MSMetabolomics quality assurance and quality control consortium (mQACC)Quality assuranceQuality controlUntargeted metabolomics

Identifiers

PMID33044703
PMCPMC7641040
OpenAlexW3091812104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.